⚖ SoapBox law
CasesDocketsStatutesRegulationsJudgesLawyersFile a complaintOversightDataLibrary

Cases

Search U.S. court opinions (CourtListener / Free Law Project), or resolve a reporter citation to its case via the Caselaw Access Project. Facts only — name, court, date, status, citation count. Never a holding-summary.

1 opinion for “WIEGAND v. MERCK SHARP & DOHME CORP.”

Court of Appeals for the Third Circuit · 2017-03-22 · Published · cited 8× · 852 F.3d 268; 2017 WL 1075047; 2017 U.S. App. LEXIS 5075
OPINION OF THE COURT FUENTES, Circuit Judge. Beginning in 2010, hundreds of plaintiffs filed personal-injury suits against the drug manufacturer Merck Sharp & Dohme, alleging that the osteoporosis drug Fosamax caused them to suffer serious thigh bone fractures. Each Plaintiff brought a state-law tort claim alleging that Merck failed to add an adequate w